The strongest, most influential medical cannabis economy in the world is not where most would think. Cue Israel, which is an agricultural superpower already and has a great green thumb for cannabis cultivation. Why? Mainly because Israel is leading the globe when it comes to legitimate cannabis research on medical applications for serious illnesses. While the U.S. dabbles with adult-use cannabis markets and state specific medical cannabis enclaves, we seriously lag when it comes to cannabis research and data, especially on the medical side. Israel, on the other hand, is leading the way in high-level studying of cannabis and its medical effects. This has led to a large amount of foreign investment into Israeli cannabis companies and research labs, and it’s also led to Israeli cannabis companies and labs bringing their talent, knowledge, and data to the U.S. — typically via intellectual property licensing agreements and joint ventures.
Israel’s relationship with medical cannabis goes way back. The country first allowed patients with qualifying conditions to use cannabis in the early 90s. According to Wikipedia, “there are eight government-sanctioned cannabis growing operations in Israel, which distribute it for medical purposes to patients who have a license from the Ministry of Health and a prescription from an authorized doctor, via either a company’s store, or in a medical center.” Perhaps most importantly,